Objective: To prepare Compound PuHuang Granules and observe its clinical efficacy on cerebral infarction.
Methods: The Compound PuHuang Granules were prepared and the identification was performed by TLC. A total of 328 patients with cerebral infarction were randomly divided into two groups and observed. 197 cases in the trial group were administered with Compound PuHuang Granules for 2 weeks, and 131 cases in the control group were administered with NaoXueShuan Tablets for 2 weeks as well.
Results: The method of identification was proved to be specific and reproductive. The effective rates of the trial group and the control group on vertigo, hemiplegia, numbness of extremities were 88.71%, 82.46%, 84.38% and 61.11%, 62.07%, 66.67%, respectively, which showed significances between the two groups (P < 0.05). But the effective rates of two groups on language disorder showed no signifcance.
Conclusions: The Compound PuHuang Granules is feasible in preparation and it has obvious efficacy, therefore, it would be useful in the clinical applications.